Profile

Dr. Steven R. Fox

BUSINESS EXPERIENCE

Akelos, Inc (2019 – Present)

  • Chairman and CEO
  • Biopharmaceutical clinical company focused on the translation of innovative science into treatment. The company currently is developing novel non-narcotic drugs for the treatment of neuropathic pain. The goal of Akelos is to address some of today’s most pressing areas of unmet needs.

iRemedy (2019 – Present)

  • Advisor

Consulting (2000 – Present)

  • Member of Board of Directors of Snap Interactive (STVI), merging it with PalTalk
  • Head of Healthcare Banking at Robert Meredith Securities
  • Registered Representative Series 7, Series 63 at Third Seven Capital
  • Owner of Shells, available for reverse mergers
  • Scarguard (Founders Stock)
  • Completed Sales of two shells to Abraxis Bio Science Inc. – a major Bio Pharmaceutical company
  • Serves on review board at the University of Pennsylvania Center For Innovation
  • Owns the premier cosmetic dental practice in New York

The Rebel Group Inc. (2000 – Present)
Chairman of the Board

Enamelon, Inc. New York, N.Y (1992-2000)
Founder, CEO and chairman of the Board

  • Pioneered the development of Enamelon, the first technology to re-mineralize tooth structure, and spearheaded its creation as an over-the-counter product, establishing and directing a company and taking it public.
  • Enamelon was sold to Church and Dwight
  • Recruited highly regarded and credentialed professionals as consultants and employees to facilitate corporate growth. These included the Assistant U.S. Surgeon General, Dean of Harvard School of Dental Medicine and several Department Chairmen, a Nobel Prize winner in Chemistry, marketing and R&D executives from Colgate, Arm & Hammer and other fortune 500 companies.
  • Negotiated advantageous technology license agreements with the Federal Government and the American Dental Association. Led the development of patents and trademarks. Capitalized on the opportunity created by technology transfer act passed by Congress, and structured foreign and domestic licenses worldwide.
  • Embarked on a large-scale campaign to raise capital, initiating a series of direct appearances, road shows, public appearances and publicity efforts, which cumulatively raised more than $75 million.
  • Business acumen and strategic planning expertise in the oversight of all FDA issues, successfully bringing product to the market without an N.D.A.
  • Guided the company to the most successful independent launch in the history of oral healthcare, achieving the number one and two SKU’s in the category, and attaining distribution into every single major chain in the country in one year, encompassing 45,000 stores. Church and Dwight now markets the brand as enamel care.
  • Positioned Enamelon as the best performing stock in the U.S. in the first quarter of 1997 by 300% across all three exchanges.
  • Established contact with news anchors and editors across the country, generating substantial publicity through hundreds of articles in the press, feature stories and appearances on TV and radio.

United Dental Examiners New York, N.Y (1978-1983)

  • Chairman of the Board
  • Built a successful company, which provided claims analysis for New York Life Insurance Co.

EDUCATION

New York University Dental College, New York, N.Y.
Doctor of Dental Surgery, Accelerated Program (1978)

University of Rochester,, Rochester, N.Y.
Bachelor of Arts; Cum Laude; Science Honors (1975)

ACCOMPLISHMENTS & AWARDS

  • U.S. Senate Medal of Freedom, Executive committee of Republican Presidential Roundtable (July 1999)
  • Ernst & Young Entrepreneur of The Year (June 1999)
  • Featured Speaker at the Forbes Conference in New York (1998)
  • Author of “Dentistry in the 21st Century”
  • Special Recognition by the United States Olympic Committee
  • Member of the Faculty of N.Y.U
  • Member of the Faculty of Harvard University
  • Officer of Harvard University